SciCombinator

Discover the most talked about and latest scientific content & concepts.

S Durgam, C Gommoll, G Forero, R Nunez, X Tang, M Mathews and DV Sheehan
Abstract
To evaluate the efficacy, safety, and tolerability of vilazodone as an acute treatment for generalized anxiety disorder (GAD). Vilazodone is a selective serotonin reuptake inhibitor and 5-HT1A receptor partial agonist approved for the treatment of major depressive disorder in adults.
Tweets*
19
Facebook likes*
2
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
0
Concepts
Cognitive behavioral therapy, Agonist, Buspirone, Tricyclic antidepressant, Generalized anxiety disorder, Sertraline, Serotonin, Selective serotonin reuptake inhibitor
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com